Fluarix Tetra

Fluarix Tetra is a quadrivalent influenza vaccine designed to protect against four strains of the flu virus. This vaccine is administered intramuscularly and is manufactured by Glaxosmithkline Biologicals S.A.

Fluarix Tetra is used to prevent influenza caused by the B/Phuket/3073/2013-like virus and the B/Austria/1359417/2020-like virus. It is typically recommended for individuals seeking protection against seasonal flu strains. The vaccine is intended for use in individuals who are at risk of complications from influenza.

Common effects of Fluarix Tetra may include soreness at the injection site, mild fever, and muscle aches. These effects are usually temporary and resolve within a few days. Severe reactions are rare but can occur.

Fluarix Tetra should be administered with caution in individuals with a history of severe allergic reactions to previous influenza vaccines. It is important to inform healthcare providers about any allergies or medical conditions before receiving the vaccine. Follow the storage and handling instructions provided to maintain the vaccine's efficacy.

Fluarix Tetra may interact with certain medications or other vaccines. It is advisable to consult a healthcare provider before receiving the vaccine if you are taking other medications or have recently received another vaccine. Alcohol and certain immune-suppressing drugs may affect the vaccine's effectiveness.